Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous nasal mucosal epithelial cell sheets for middle ear cholesteatoma
jRCT2033210438Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Dec 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous nasal mucosal epithelial cell sheet in Cholesteatoma and chronic otitis media (COM), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Mastoid cavity aeration at 48 weeks. Started Dec 2021; status: completed.
02
Drugs
autologous nasal mucosal epithelial cell sheet
03
Conditions
Cholesteatomachronic otitis media (COM)
Beyond the preview
Go deeper on jRCT2033210438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033210438.